Department of Medicine

University of Pittsburgh

Division of Rheumatology and Clinical Immunology
S700 Biomedical Science Tower
3500 Terrace Street
Pittsburgh, PA 15261
Phone: (412) 383-8000

Larry Moreland, MD
photo

Margaret Jane Miller Endowed Professor of Arthritis Research

Chief, Division of Rheumatology and Clinical Immunology
 
Phone: 412-383-8734
Fax: 412-648-8894
E-mail: morelandl@dom.pitt.edu
Education
BS, West Liberty State College, 1979
MD, West Virginia University, 1983
Training
Internship (Internal Medicine), West Virginia University Medical Center, 1984
Residency (Internal Medicine), West Virginia University Medical Center, 1986
Chief Medical Residency, West Virginia University Medical Center, 1987
Fellowship,Rheumatology & Clinical Immunology, University of Alabama at Birmingham, 1990
Area of Specialization/Research Interest  
Rheumatoid Arthritis
Ankylosing Spondylitis
Osteoarthritis
Psoriatic Arthritis
Autoimmune diseases
 
Profile
Dr. Moreland’s research focuses on therapies for various autoimmune diseases (rheumatoid arthritis, vasculitis, systemic lupus erythematosus, spondyloarthropathies) and osteoarthritis. He and collaborators have established multicenter collaborative efforts in several areas of research. Examples of active research include evaluating genetic and environmental factors in pathogenesis of African Americans with rheumatoid arthritis, evaluating efficacy (and molecular mechanisms) of various disease modifying agents used to treat rheumatoid arthritis, and new approaches aimed at developing disease remission for patients with rheumatoid arthritis.
Recent Grants
Title: Consortium for the Longitudinal Evaluation of African Americans with early Rheumatoid Arthritis (CLEAR) Funding Agency: NIH Dates: 2006 – 2009
Role: Co-Investigator
Amount:
Funding Agency: NIH
Start Year: 2006
End Year: 2009
Title: Anti-tumor necrosis factor (TNF-blocking) agents: Mechanism of Failure in Rheumatoid Arthritis subjects
Role: Principal Investigator
Amount:
Funding Agency: NIH
Start Year: 2006
End Year: 2009
Title: Switching anti-TNF and agents in patients with rheumatoid arthritis and an inadequate response to TNF  inhibitor
Role: Co-Investigator
Amount:
Funding Agency: NIH
Start Year: 2006
End Year: 2009
Title: Predictors of treatment response in early RA
Role: Co- Investigator
Amount:
Funding Agency: NIH
Start Year: 2004
End Year: 2008
Title: Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Role: Principal Investigator
Amount:
Funding Agency: Amgen
Start Year: 2003
End Year: 2010